Atlantic Healthcare Announces Results from Phase 3 Trial of Alicaforsen Enema for Orphan-Designated Pouchitis
Cambridge, UK; July 31, 2019. Atlantic Healthcare plc (“Atlantic Healthcare” or…
Atlantic Healthcare plc acquires global rights to renzapride for the treatment of gastrointestinal motility disorders
Cambridge, UK; June 26, 2019. Atlantic Healthcare plc (“Atlantic Healthcare” or…
Atlantic Healthcare to attend DDW in San Diego, May 18-21
Cambridge, UK; May 1, 2019. Atlantic Healthcare plc (“Atlantic Healthcare” or…
Atlantic Healthcare to attend BIO-Europe Spring in Vienna, March 23-25
Cambridge, UK; March 12, 2019. Atlantic Healthcare plc (“Atlantic Healthcare”…
Atlantic Healthcare to present at the Piper Jaffray 2018 Healthcare Conference in New York on November 27 (10.10 - 10.30 ET)
Cambridge, UK; November 26, 2018. Atlantic Healthcare plc (“Atlantic…
Atlantic Healthcare to present at the Stifel 2018 Healthcare Conference in New York on Wednesday, November 14
Cambridge, UK; November 12, 2018. Atlantic Healthcare plc (“Atlantic…
Atlantic Healthcare to present a poster at the Crohn’s & Colitis Foundation IBD: Innovate conference in New York on Tuesday, November 13, 2018
Cambridge, UK; November 12, 2018. Atlantic Healthcare plc (“Atlantic…
Atlantic Healthcare reports results from Phase 1 trial of tablet for Crohn’s
Oral alicaforsen appears safe and well-tolerated Cambridge, UK; 27 September…
Atlantic Healthcare secures acceptance of brand name Camligo™ for alicaforsen enema to treat pouchitis
Cambridge, UK; September 13, 2018. Atlantic Healthcare plc (“Atlantic…
Strategic appointment expands Atlantic Healthcare executive team
Cambridge, UK; August 2, 2018. Atlantic Healthcare plc (Atlantic Healthcare), a…